Back to today’s briefing

Story perspectives

Lupiwighteone Leads Fight Against Dengue Virus with Safety

8/2/2025

37 7

Summary

Story summary

Lupiwighteone has emerged as a frontrunner in the battle against the dengue virus, exhibiting strong binding affinities with key proteins NS3, NS5, and E. With impressive pharmacokinetic and safety profiles, it stands apart from Baicalein and KushenolW, which were sidelined due to toxicity concerns. Daclatasvir also shows promise, boasting zero toxicity and paving the way for further exploration.

1 of 1

Story summary

Lupiwighteone has emerged as a frontrunner in the battle against the dengue virus, exhibiting strong binding affinities with key proteins NS3, NS5, and E. With impressive pharmacokinetic and safety profiles, it stands apart from Baicalein and KushenolW, which were sidelined due to toxicity concerns. Daclatasvir also shows promise, boasting zero toxicity and paving the way for further exploration.